New inhaled treatment tested for serious lung and heart condition
Disease control
Completed
This Phase 3 study tested whether an inhaled drug called seralutinib could help adults with pulmonary arterial hypertension (PAH), a serious condition affecting blood vessels in the lungs and heart. The main goal was to see if the drug improved patients' ability to walk and delay…
Phase: PHASE3 • Sponsor: GB002, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC